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Abstract
Our aim is to assess the subfield-specific histopathological correlates of hippocampal volume
and intensity changes (T1, T2) as well as diffusion MRI markers in TLE, and investigate the
efficacy of quantitative MRI measures in predicting histopathology in vivo. We correlated in vivo
volumetry, T2 signal, quantitative T1 mapping, as well as diffusion MRI parameters with
histological features of hippocampal sclerosis in a subfield-specific manner. We made use of on
an advanced co-registration pipeline that provided a seamless integration of preoperative 3T MRI
with post-operative histopathological data, on which metrics of cell loss and gliosis were
quantitatively assessed in CA1, CA2/3, and CA4/DG. MRI volumes across all subfields were
positively correlated with neuronal density and size. Higher T2 intensity related to increased
GFAP fraction in CA1, while quantitative T1 and diffusion MRI parameters showed negative
correlations with neuronal density and/or size in CA4/DG/. Subfield-based multiple linear
regression analysis revealed that in vivo multi-parametric MRI can predict neuronal loss in all
subfields with up to 97% accuracy. Our results, based on an accurate co-registration pipeline and
a subfield-specific analysis of MRI and histology, demonstrate the potential of MRI volumetry,
diffusion, and quantitative T1 as accurate in vivo biomarkers of hippocampal subfield pathology.
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Introduction
Temporal lobe epilepsy (TLE) is the most common form of drug-resistant epilepsy in adults 1.
Hippocampal sclerosis (HS) is the histopathological hallmark of TLE and the most common
underlying etiology 2. It is characterized by cell loss and gliosis in the hippocampal formation,
with substantial individual variability in the extent and spatial distribution of these changes.
Since early pathological descriptions 3, it has been widely accepted that subfields such as Cornu
Ammonis (CA) 1, CA3, CA4, and the dentate gyrus present with marked changes, while CA2 is
relatively spared 4. Across patients, HS encompasses a broad spectrum of structural changes,
which can be categorized into different subtypes based on neuropathological grading systems 5-7.
Previous findings have suggested an association between histopathological subtypes,
postsurgical seizure outcomes, and postoperative memory impairment

6-9

. In-vivo prediction of

distinct subfield atrophy may lead to more accurate TLE diagnosis and improved patient
management. It may also play an important role in the early detection and treatment of other
neurological and neurodegenerative diseases, such as Alzheimer’s disease (West, 2004), stress
(McEwen, 1997) or schizophrenia (Harrison, 2004), where the subfields are selectively affected.

MRI has played a key role in the pre-surgical evaluation of TLE, with in-vivo volumetry
and T2-MRI showing a high utility in identifying HS

10-20

. Landmark studies have shown that

global hippocampal atrophy correlates with pathological grades of hippocampal cell loss 10; and
that T2 signal mainly relates to glial cell count, particularly in the dentate gyrus 19. While these
studies represent important steps towards a histopathological validation of MRI markers of HS,
assessments have been carried out either on the whole hippocampus or have been restricted to

3

single subfields. Moreover, comparisons between the resected tissue and MRI did not employ
rigorous data co-registration that would allow for a regionally specific correlation between invivo MRI and histological features. Finally, although previous reports have suggested that
diffusion assessments may be a sensitive marker of HS-related changes

21

, the exact

histopathological correlate of abnormal diffusion in TLE has not been established in humans.

The current study aims to assess the subfield-specific histopathological correlates of an
ensemble of advanced MRI markers. Specifically, we evaluated hippocampal volume, T2
intensity, quantitative T1 and diffusion MRI markers in TLE, and investigated their efficacy in
predicting histopathology in vivo. Our analysis framework is built on a unique co-registration
pipeline that allows for seamless integration of preoperative high-resolution MRI with postoperative histopathological data, on which metrics of cell loss and gliosis were quantitatively
assessed.

Materials and methods
Patients and Samples
The subjects in this study were 15 patients with drug-resistant TLE (7 males and 8 females,
age=36±12 years, range=20-59 years), who underwent anterior temporal lobectomy (ATL) with
amygdalohippocampectomy surgery at the London Health Sciences Centre. The hippocampal
specimens were resected en-bloc by two surgeons at our centre, with minimal use of ultrasonic
aspiration. All subjects underwent preoperative 1.5 Tesla clinical MRI (acquiring T1-weighted,
T2-weighted, FLAIR, and diffusion-weighted sequences) and neuropsychological testing, as part
of their pre-surgical evaluation. Video-scalp EEG telemetry was employed to identify the
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epileptogenic zone, with four patients needing subdural electrode placement to better localize
their seizures onset zone. In addition to the 1.5 T conventional MRI sequences, subjects
underwent a series of scans on a 3.0 T research scanner as described in the in-vivo MRI imaging
subsection. Table 1 summarizes the clinical and demographic information for our cohort. Fifteen
subjects were originally recruited, however two were discarded from the analysis as the
hippocampi were fragmented, and there was insufficient tissue to clinically assess HS or perform
automated neuron analysis. Informed consent was collected from all participants prior to their
recruitment in the study. This project was approved by the office of Research Ethics of Western
University.

MRI acquisition
a) In-vivo acquisition
All patients underwent in vivo imaging on a 3.0 T Discovery MR750 scanner (General Electric,
Milwaukee, WI, USA) using a 32 channel head coil. The DESPOT1-HIFI technique

22

was

employed for quantitative T1 mapping, whereby two 3D spoiled gradient echo (SPGR) sagittal
T1-weighted scans (TR=8.36 ms, TE=3.71 ms, flip angles =4°/18°, matrix=220x220, slice
thickness=1 mm, FOV=220x220 mm2), as well as an additional sagittal inversion-prepared
SPGR volume for B1 mapping (TR=6.4 ms, TE=3.1 ms, flip angle=5°, matrix=220x128, slice
thickness=1 mm, FOV=220x200 mm2) were acquired. For T2-weighted MRI, we employed a
sagittal balanced steady-state free precession (bSSFP) sequence (TR=4.6 ms, TE=2.3 ms, flip
angles=35°, matrix=220x220, slice thickness=1 mm, FOV=220x220 mm2). T2 intensity values
were normalized with respect to mean intensity in a spherical region in the lateral ventricle
ipsilateral to the HS for each patient. An axial spin-echo echo-planar imaging (EPI) sequence
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was used to obtain diffusion weighted MRI, with a b-value of 1000 s/mm2 and 41 diffusion
directions (TR=1100 ms, TE=63.2 ms, flip angle=90°, matrix=96x96, slice thickness=2.5 mm,
FOV=240x240 mm2).

b) Ex-vivo specimen acquisition
In order to validate our in-vivo DTI measurements, high-resolution ex-vivo DTI was performed
on cases where overnight imaging was feasible and not disruptive to the clinical

workflow (N=5). Scanning was performed on a 9.4T small bore Varian MR magnet
(Varian, Palo Alto, CA, U.S.A) in a millipede birdcage MP30 coil (Agilent, Santa Clara,
CA, U.S.A) after overnight fixation in 10% formalin. Each specimen was immersed in a
fluorine-based lubricant ‘Christo-lube MCG 1046’ (Lubrication Technology, Inc) prior to
imaging to avoid susceptibility artifacts at the tissue boundaries. Spin-echo diffusion

sequences were acquired (TR = 7.6 ms, TE = 3.8 ms, slice thickness = 0.4mm) with an
in-plane resolution of 0.1×0.1 mm and FOV of 38×25.6 mm. We also acquired structural
images employing a balanced steady-state free precession sequence (TrueFISP, TR = 7.6
ms, TE = 3.8 ms, flip angle = 30◦, resolution = 0.1 mm isotropic, FOV= 38×25.6×19.2
mm) for in-vivo to ex-vivo image registration.

MRI processing
a) Quantitative T1

6

The T1-weighted volumes co-registered to the first image volume of the session using a rigid
transformation obtained with FLIRT (FSL 4.1, http://fsl.fmrib.ox.ac.uk). Quantitative T1 maps
were reconstructed using the approach described by Deoni et al.22.

b) Diffusion MRI
Non-linear distortions were corrected by deformable registration of the average unweighted
volume to the undistorted T1 map using a diffeomorphic registration method

23, 24

. FMRIB’s

Diffusion Toolbox (FDT) was used for motion and eddy current correction and estimation of the
diffusion tensor. In addition, we computed the two diffusion tensor imaging (DTI) parameters;
fractional anisotropy (FA) and mean diffusivity (MD), also known as apparent diffusion
coefficient (ADC), which are the most commonly used indices in the epilepsy literature, defined
as:

𝐹𝐹𝐹𝐹 =

�3[(𝜆𝜆1 − 〈𝜆𝜆〉)2 + (𝜆𝜆2 − 〈𝜆𝜆〉)2 + (𝜆𝜆3 − 〈𝜆𝜆〉)2

where

�2(𝜆𝜆12 + 𝜆𝜆22 + 𝜆𝜆23 )

〈𝜆𝜆〉 = 𝑀𝑀𝑀𝑀 =

,

(𝜆𝜆1 + 𝜆𝜆2 + 𝜆𝜆3 )
,
3

𝜆𝜆1 , 𝜆𝜆2 , 𝜆𝜆3 are the eigenvalues of the diffusion tensor. Using linear registration (FLIRT), we

transformed and resampled the resulting diffusion maps to the coordinate system defined by T1
map (1 mm isotropic voxel size).

Quantitative histology
7

Resected specimens underwent accessioning and gross description by the Department of
Pathology at London Health Sciences Centre. The numerous challenges in our quantitative
histology pipeline include the high complexity of en-bloc resections, as the difficulty in
preserving atrophic hippocampi throughout histological processing, and the tendency for the
tissue to deform and occasionally form fissures (partially due to the differential shrinkage of gray
and white matter). To better preserve specimen architecture, the samples were bissected in the
coronal plane and each half embedded in agar for stabilization and support during processing and
sectioning. Each half was sectioned into thick coronal slices (4.4 mm spacing), parallel to the
initial cut using a deli slicer. Blocks were then embedded in paraffin and sectioned at a thickness
of 8 µm. Hematoxylin and eosin (H&E) stain was applied to slides from each block, in addition
to the following immunohistochemical (IHC) stains: neuronal nuclear protein (NeuN)
(monoclonal antibody; 1:400; EMD Millipore, Billerica, Massachusetts) as a marker for neuronal
nuclei and the perinuclear soma, and GFAP (polyclonal antibody; 1:4000; Dako, Agilent
Technologies, Santa Clara, California) as a marker for gliosis. To minimize variability between
slides, batch IHC processing was performed on a Dako Autostainer Link 48. Resulting slides
were digitized on a ScanScope GL (Aperio Technologies, Vista, CA, USA) bright field slide
scanning system at a maximum of 20x optical zoom, and automatically stitched to form fullframe multi-resolution images stored in BigTIFF file format (maximum pixel resolution 0.5 μm).

We quantified NeuN using field fraction estimates (i.e., the proportion of pixels in the
field that are positively-stained). These estimates are sensitive to the packing density and cellsize of neuronal cell bodies and processes and have been previously employed to represent
neuronal integrity 25-27. Similarly, we quantified field fraction estimates of GFAP IHC, which is
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sensitive to reactive astrogliosis and analyzed the full resolution slides in blocks of 100x100 um
using MATLAB (The MathWorks Inc., Natick, MA, USA). To provide local estimates of neuron
density and size we developed a method for segmenting cell bodies of pyramidal and granular
neurons. This technique first extracts the colour component related to immuno-positive staining
using colour deconvolution

28

preceding a watershed-based segmentation procedure

29

for

splitting joined or connected neurons, and removes objects smaller than a predefined area
defined as noise (less than 14 μm2). Resulting neuron segmentations provide the neuronal density
(number of neurons) per field, as well as the mean area (size) of cell bodies, within the field. To
further discriminate between pyramidal neurons of the CA subfields and granular neurons of the
dentate gyrus, we used area thresholds (125 and 50 µm2 respectively). Neuron-specific
quantitative features in each field of these images were extracted using a custom algorithm
written in MATLAB. Manual counts taken from two randomly selected fields per slice within
the CA subfields and the dentate gyrus by one rater (blinded to the automated counts) were
employed to validate our automated cell segmentation for pyramidal and granular neuron
quantification. Automated (A) and manual (M) segmentation achieved a high agreement Kappa
(κ) = (A-M) / (1-M) = 98% for pyramidal cell counts and κ = 96% for granular cell counts.
Figure 1 illustrates this procedure and demonstrates the quantitative histological features:
neuronal density (for both CA and DG), mean neuron size, and GFAP field fraction. Neuronal
density data from the least sclerotic specimens were used as references to compute percent cell
loss per subfield for each patient. We generated as well a three-level (1: no HS, 2: moderate, 3:
severe) qualitative HS subtype classification based on expert clinical assessment that combined
radiological and histology reports. The second level definition was based on moderate CA1
atrophy or mild involvement of both CA1 and C4. The third level was based on severe global

9

atrophy in CA1 and CA3 & 4. No subject presented as atypical CA4-only atrophy in our cohort,
either in the histology reports or the quantitative analysis.

Histology feature extraction
A single rater (MG) manually delineated hippocampal subfields on histology slices,
downsampled to 20µm pixel size using ITKSNAP

30

, and were confirmed by neuropathologist

(RH). Our segmentation protocol is based on the Duvernoy hippocampus atlas

31

, with the

following boundary definitions: The border between the subiculum and CA1 was defined as a
horizontal line at the edge of the subiculum extending from the inferior border of the dentate
gyrus and the hippocampal sulcus, as shown in the top row of Figure 2. The CA1/CA2 boundary
was designated as the point at which a noticeable decrease in width of the CA1 subfield was
observed, following the most lateral point of the DG. The CA2/CA3 boundary was defined at the
most medial point of the superior curve of the dentate gyrus where a gradient of pyramidal cell
density is observed between the subfields. The opening of subfields into the globular region of
the hippocampal formation formed the CA3/CA4 border. The remaining globular region of the
hippocampal formation was marked as CA4. The dentate gyrus was divided into two labels, one
encompassing the granular layer and another combining both molecular and polymorphic layers
surrounding the granular cells. Figure 2 shows examples of subfield delineation on histology
slices from three patients from our cohort with mild, moderate and severe sclerosis.

MRI parameter extraction
We first applied our previously described MRI to histology

32, 33

registration pipeline, which

allowed for the identification of the MRI slice that best corresponded to the cut histology slice
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(Figure 3). Instead of relying on imaging parameters from segmented subfields along the entire
length of the hippocampus, parameters can be analyzed from a select target region encompassing
the MRI slice corresponding to a given histological slice. For more robust correlations, we
modelled uncertainty stemming from registration (approx. 2.5 mm)

32, 33

and histological

sectioning errors (variance in sectioning histology slices from the face of blocks, approx. 1 mm)
34

. Specifically, MRI data adjacent to the corresponding slice were cropped and weighted using a

sinc function with FWHM=3mm, giving data adjacent to the closest corresponding MRI slice in
the sagittal plane a higher weighting than those more distant.

Within a given target region, subfields were then manually segmented by a single rater
(MG). This segmentation protocol mirrors that employed on histology and is similar to that
described in our previous work at 7.0 T 35. The MRI protocol was confirmed by consensus with a
neurologist (NB) and a neuropathologist (RH). Assessment was restricted to CA1, CA2/3, and
CA4/DG. It should be noted that MRI parameter extraction was performed in the intrinsic in vivo
space (1 mm isotropic) and not the upsampled space to avoid resampling the quantitative maps.

Statistical analysis
Statistical analyses were performed using SPSS statistics (version 20, IBM, Armonk, NY) and
JMP statistical software (version 10, SAS, Cary, NC). Prior to analysis, MRI parameters and
histological features were internally z-scored. It should be noted that DTI measures were only
assessed in CA1 and CA4/DG in the subfield-specific analysis, due to the lower native resolution
of the diffusion MRI acquisition. The statistical analysis was stratified into four distinct
experiments:

11

A. MRI-histology correlations

i.

Univariate correlation analysis

We systematically assessed pair-wise, non-parametric (Spearman Rho) correlations between
individual histological parameters relating to neuronal characteristics (neuronal size and density)
and putative MRI markers of neuronal loss (subfield volume and T1 intensity

36

). In a second

step, we evaluated correlations between histological GFAP field fraction and MRI-derived T2-w
intensity. In a more exploratory diffusion-histology assessment, we correlated histological
parameters with FA and MD. Multiple comparisons were corrected at a family-wise error (FWE)
of p < 0.05 using non-parametric permutation tests

37

. Permutation tests were performed

in MATLAB based on two-tailed Spearman rank correlations with 100,000 random
permutations. The family-wise error corrected p-values (alpha=0.05) for each comparison were
obtained using the distribution of the most extreme statistic calculated for each permutation.

ii.

Multiple linear regressions.

To test the efficacy of quantitative, multi-parametric MRI in pre-operatively predicting neuronal
loss per subfield, multiple linear regression analyses were performed between a) subfieldspecific MRI parameters and percent loss of neurons for each subfield, b) MRI parameters from
all subfields and percent neuronal loss for each subfield.

B. Clinical correlations
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In addition, we assessed the correlations between each of the above variables and clinical
variables such as age of seizure onset, duration of epilepsy and short-term Engel seizure
outcome.

C. Validation Experiments
We performed three experiments to validate our in-vivo DTI measurements and provide further
evidence that our correlation analysis is not driven by single outliers or confounds such as the
partial volume effect.
i.

High-resolution ex-vivo DTI

This experiment was performed with the aim of validating our in-vivo DTI measurements with
higher resolution ex-vivo data. We first employed our registration pipeline to obtain a mapping
between ex-vivo data and histology then warped the histology labels to the ex-vivo space. These
labels were then used to initialize the segmentation and to define the ex-vivo corresponding
slices. Segmentation adjustments were applied by the same rater (if needed post-registration) on
T2-weighted structural images, prior to extraction of diffusion parameters from FA and MD
maps and comparison with in-vivo measurements. Voxels at the gray matter-CSF boundary (in
CA1 and CA2) were not segmented to avoid CSF contamination in our validation datasets.
Correlation coefficients were computed between both scanning sessions for both diffusion
parameters.
ii.

Label Erosion

In addition, we eroded the subfield segmentation labels inward and repeated all the univariate
correlation analysis as a further demonstration that partial volume effects did not influence our
results.
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iii.

Bootstrapping

We employed the bootstrapping technique, with a sample size of 1000 and 95% bias corrected
confidence intervals on all the tested correlations, to better estimate the confidence intervals of
the presented correlation coefficients and ensure the reliability of our results. We will present the
results of this experiment alongside the univariate correlation results, where each correlation
coefficient is followed by its 95% bias corrected lower and upper confidence intervals from
bootstrapping.

Results
A. MRI-histology correlations
i.

Univariate correlations (Table 2 and Figure 4).

Across all subfields, we observed a consistent positive correlation between MRI-derived subfield
volume and histology-derived neuronal density and size, with highest effect sizes in CA1
(density: rs = 0.910 (0.633, 0.997), pfwe < 0.001, and size: rs = 0.830 (0.302, 0.994), pfwe < 0.001).
Correlations for the other parameters were confined to single subfields. Specifically, MD was
negatively correlated with pyramidal cell density within CA4/DG (rs = -0.833 (-0.479, -0.975),
pfwe < 0.001) and T1 negatively correlated with both neuronal markers in the same subfield (size:
rs = -0.830 (-0.497, -0.994), pfwe < 0.001, and density: rs = -0.781 (-0.320, -0.966), pfwe = 0.006).
On the other hand, higher T2-weighted intensity related to increased GFAP fraction in CA1 (rs =
0.835 (0.518, 0.950), pfwe < 0.001).

ii.

Multiple linear regressions.
a)

Subfield-specific
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Multiple linear regression analysis demonstrated that multi-parametric MRI can accurately
predict subfield neuronal loss. Across all subfields, volume was a consistent feature, and was
selected together with T2 in CA1 (adjusted R2 = 0.88, p < 0.001), with T1 in CA2/3 (adjusted R2
= 0.73, p = 0.001) and second to MD in CA4/DG (adjusted R2 = 0.70, p = 0.005).
b)

Cross subfields regressions

As for MRI parameters from all subfields, CA4/DG volume as well as CA1 T1 and FA,
predicted CA1 percent neuronal loss with high accuracy (adjusted R2 = 0.90, p < 0.001). Volume
and T1 parameters from CA2/3 as well as CA4/DG MD and T2 predicted CA2/3 percent loss
with very high accuracy (adjusted R2 = 0.96, p < 0.001). Finally, loss in CA4 was predicted with
equivalent accuracy using CA4/DG and CA2/3 volume and MD (adjusted R2 = 0.97, p < 0.001).
Table 3 summarizes the multiple linear regression results for the subfield-specific experiment.
The model fit for the prediction of neuronal loss of the four analyzed subfields from subfieldspecific parameters is presented in Figure 5.

B. Clinical correlations
In the subfield-specific correlation analysis, only CA2/3 T1 negatively correlated with short-term
Engel outcomes with prolonged T1 values relating to better outcomes (r = -0.701, pfwe = 0.012)
and similarly CA4 GFAP field fraction was the only histological feature to correlate with
outcomes with increased gliosis in CA4 associating with worse outcomes (r = 0.695, pfwe =
0.012). Moreover, our qualitative HS subtypes classification (based on clinical MRI and
histology reports) correlated with quantitative neuronal density within the three CA subfields
(CA1: r = 0.842, p < 0.001, CA2/3: r = 0.755, p = 0.003, CA4: r = 0.920, p < 0.001).
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C. Validation experiments
i.

High-resolution ex-vivo DTI

Figure 6 presents the comparison between in-vivo and ex-vivo diffusion parameters (FA and
MD) for five subjects. The good agreement between the two sessions, in both CA4 as well CA1,
provides support for the much larger voxel size present in the in-vivo diffusion measurements.
CA4 had higher correlations, between ex-vivo and in-vivo DTI for both MD (r = 0.88) and FA (r
= 0.72), than CA1 (MD: r = 0.58, FA= r = 0.52). This could be due to the curved shape of CA1,
which compromises gray matter values adjacent to CSF in in-vivo imaging. The shift in diffusion
measurements, highlighted by the graphs in the figure, between in-vivo and ex-vivo is probably
attributed to fixation and tissue processing effects on the specimens’ microstructure. CA2 and 3
were not included in this analysis due to their relatively smaller size compared to our in-vivo DTI
voxel size.
ii.

Label erosion

Findings remained highly significant even when subfield labels were eroded prior to analysis as
described earlier, suggesting minimal confounds due to partial volume effect (Suppl. Table 1).

Discussion
This is the first study to investigate the histopathological substrates of volume, T2, quantitative
T1 relaxometry while employing high resolution maps at 3.0 T and a comprehensive mapping
between MRI and pathology. A number of studies previously correlated T2 and volumetry with
pathology in the context of hippocampal sclerosis

10-20

. However, they only focused on whole

hippocampus MRI parameters or correlated pathology findings on a histology slice with subfield
parameters extracted from the entire hippocampus or employed in vivo scans with low out-of-
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plane resolution (> 3 mm) and no registration was preformed to establish correspondences
between MRI and histology 12-15, 17, 18. Although previous studies investigated diffusion changes
in patients with HS and demonstrated increased MD as well as decreased FA in the ipsilateral
hippocampi and white matter

38-42

, this is the first to investigate histopathological correlates of

diffusion metrics in TLE within the hippocampal subfields. Our registration protocol validates
our high-resolution MRI maps with quantitative histology to better understand the pathological
substrates of our imaging findings. These features may be more sensitive to neuronal
degeneration as distinct from qualitative assessment or quantitative grading of neuronal loss as
they provide a continuous measurement of pathologies.

Biological Interpretations
In our correlation analysis, pre-operative subfield volumetry was highly correlated with subfield
density (specifically in CA1). Numerous studies have reported that neuronal density within the
subfield may directly relate to volume atrophy

10, 11, 13, 19, 20

. The presented subfield-specific

correlation analyses confirmed these previous findings.

Mean diffusivity was the most prominent MRI marker, other than volume, for neuronal
density. In our subfield-specific analysis, MD was negatively correlated with neuronal density
and size of CA4, demonstrating the importance of this MRI parameter in determining subtypes
pre-operatively. A previous study analyzing relationships between diffusion maps and cell
density in malignant brain tumours described an analogous association between MD and tumour
core cell density 43. The loss of neurons in the hippocampal subfields may lead to less restricted,
water diffusion and thus higher diffusivity. A similar interpretation can be described for the
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relationship between MD and neuronal size: as neuronal cell bodies shrink, the proportion of
intra-neuronal water is reduced thereby increasing diffusivity. Given the limitations of in-vivo
DTI, we cannot precisely assess the nature of the architectural changes related to MD, but we
hope to explore these issues further using high-resolution ex-vivo DTI of the resected specimens.

It has been suggested

19

that in-vivo T2 relaxation relates to dentate glial cell count,

whereas a more recent study found no correlation between ex-vivo T2-w and GFAP field
fraction in the subfields 44. In our results, T2 also correlated with increased GFAP field fraction
expression in CA1, which represents reactive gliosis (astrocytic and microglial proliferation), but
failed to show a significant correlation in the dentate gyrus. T1 was correlated as well with
neuronal size/density in CA4. An analogous relationship between ex-vivo GM T1 values and
neuronal density has been previously described in patients with multiple sclerosis

45

. Cell loss

will likely result in an increase in the extra-cellular space, thus the intra-cellular water will
decrease as extra-cellular water increases, which in turn would increase T1 46. The presence of a
significant association between T1 and neuronal markers in CA4/DG may be due to the high
content of zinc in the mossy fiber projections from the dentate gyrus

47

. Our previous study

36

,

focused on investigating the histopathological correlates of quantitative MRI within the
neocortex, demonstrated that in-vivo T1 and FA negatively correlated with density of small
caliber neurons. We did not see this relationship for FA in this analysis of the hippocampus,
which could be due to the inherent differences in myeloarchitecture and cytoarchitecture that
exist between the hippocampus and lateral neocortex. Both studies confirm the power of
quantitative T1 mapping and diffusion MRI as in vivo biomarkers for hippocampal and
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neocortical pathology in TLE, and their potential use to detect pathology in other neurological
disorders.

Clinical findings and insights
Multiple linear regression analysis revealed that volume and MD are the most prominent
parameters in predicting neuronal loss, with increased accuracy when adding T2. This
observation mirrors the correlation analysis where MD and volume were the parameters with the
highest number of associations with histological features. T2 was correlated with GFAP field
fraction in CA1 whereas MD was correlated with density in CA4, while both have similar
insignificant trends in other subfields. A larger cohort may be needed to observe their predictive
ability in other subfields. Hippocampal neuronal loss has been previously shown to potentially
predict patient outcomes

48

and memory deficits

49

. Predicting subfield loss from in vivo

quantitative MRI has the potential to non-invasively localize pathology and determine the extent
of hippocampal atrophy, with a precision previously unachievable. It may also help classify
patients into different HS subtypes and decide on the merit of their surgical candidacy.
Moreover, it may help identify select hippocampal subfields for targeting electrodes used for
neurostimulation therapy or MRI-guided laser ablation, as an alternative to resective surgical
intervention.

The association between the qualitative HS subtype classification and neuronal density
within the CA subfields, validates the accuracy of our automated neuron quantification
procedure. Some reports have previously shown that hippocampal sclerosis subtypes have
different post-operative outcomes 8, 9, and correlate with seizure duration and onset 50. The Engel
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outcomes presented in this study are reported in the short-term follow up with the average time
since surgery for our cohort being just under two years (22 months). CA2/3 T1 was the only invivo MRI parameter to correlate with outcomes in our cohort, which mirrors the classification
results demonstrating CA2’s ability to represent the spectrum of atrophy across patients.

Limitations and technical considerations
A limitation of this work is the lack of normative control data for histology, and hence in our
assessment, the least sclerotic specimens were used as reference for computation of percentage
cell loss. We also employed histological measurements from one optimal slide per subject, which
may have biased the results. This was due to the restricted size of the resected specimens (only a
fraction of the hippocampus is resected at times) and the large variability in specimen sizes, as
well as effects of tissue breakage and fragmentations. These limitations, in addition to the need
to reserve part of the specimen in tissue banks for clinical use, restricted the analysis to a
maximum of one histology slide (for some subjects) where all the CA subfields are clearly
visible. In addition, we employed an approximation of T2 values using intensity-normalized T2weighted images, as some failed T2-weighted acquisitions for an earlier subset of patients
prevented us from computing DESPOT2 for all subjects. We opted to manually segment the
subfields on MRI, instead of relying on an automated technique, which uses a statistical model
with Markov random field priors to delineate subfield boundaries based on T1-weighted
MPRAGE MR sequences 20. Although this approach is more time consuming and possibly prone
to rater-bias, it produces more accurate labels specifically in very sclerotic hippocampi, and
those with malrotation where the image signal to noise, contrast and resolution, as well as
morphology are not sufficient to guide the automated technique. Another way to correlate pre20

operative MRI and pathology is through direct registration of both modalities
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and warping of

regions of interest from histology to in vivo space. However, for this technique to be effective,
image resolution of pre-operative volumes needs to be sub-millimetric. For example, if in vivo
maps have a 1 mm isotropic resolution, smaller subfields (i.e. CA2 and CA3) warped from
histology would only occupy 2 or 3 voxels on a slice in the in-vivo space, which would challenge
the accuracy of the results.

Conclusion
This is the first study to investigate the histopathological substrates of in vivo volume, T2,
quantitative T1 relaxometry while employing high resolution maps at 3.0 T and a comprehensive
mapping between MRI and pathology. It is also the first direct investigation of histopathological
correlates of diffusion metrics in TLE within the hippocampal subfields. Moreover, we
developed and validated an automated quantitative histology procedure for quantification of
neuronal density, size and NeuN and GFAP field fractions. We have demonstrated that volume,
MD and T1 are sensitive markers for neuronal integrity in the subfields and confirmed that T2 is
a marker of gliosis. Finally, we have shown that in vivo multi-parametric MRI can predict
subfield neuronal loss in all subfields with very high accuracy. This work suggests that in vivo
subfield volumetry, diffusion and quantitative MRI have the potential to non-invasively localize
pathology and determine the extent of hippocampal subfield atrophy, with increased precision.
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Figure Legends
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Figure 1. Overview of some of the quantitative histological features including: neuron density,
mean neuron size, and GFAP field fraction.

29

Figure 2. Subfield delineation on histology slices from three patients from our cohort (Top: Mild
sclerosis, Middle: Moderate sclerosis, Bottom: Severe sclerosis). The labeling scheme (colour
representing each subfield) is described at the bottom of the figure.
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Figure 3. Schematic outline of MRI parameter extraction in the subfields. 1) Determination of
the MRI slice best corresponding to a histology cut by employing a MRI-histology coregistration pipeline (with the ex-vivo MRI as an intermediate step). 2) Extraction of a subjectspecific, target region surrounding the ‘corresponding MRI slice’, to model registration and
sectioning uncertainty. 3) Manual delineation of the subfields within the chosen target region and
application of a sinc sagittal weighting kernel (producing lower weighting away from the
corresponding slice).
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Figure 4. Selection of significant associations from Spearman’s correlation analysis for subfieldspecific MRI parameters with histological features.
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Figure 5. Multiple linear regression results for subfield-specific parameters depicting predicted
vs. actual percent neuron loss for each of the four CA subfields.
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Figure 6. High-resolution ex-vivo validation of in-vivo DTI measurements. The top row depicts
warping of the subfields from histology to the registered ex-vivo space for one subject and
compares them to the in-vivo subfield segmentation (A: Axial, S: Sagittal, C: Coronal). Rows
two and three demonstrate the comparison between in-vivo and ex-vivo DTI parameters
[fractional anisotropy (FA) (middle row) and mean diffusivity (MD) (bottom row)] for both CA1
(middle) and CA4 (right).
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